Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MNPR
#2866
Monopar Therapeutics Inc. - Common Stock
72.0
8
USD
-0.06%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-6.45%
Monthly Change
-35.64%
6 month change
+24.95%
Year Change
+31.97%
Previous Close
77.0
5
Open
75.6
0
Low
71.6
6
High
76.9
2
Markets
US Stock Market
Healthcare
Biotechnology
MNPR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2018
Current report, 04 Jun 2018
2018.06.05
Monopar Therapeutics current report, 04 June 2018
8-K
Quarterly report, Q1 FY2018
2018.05.11
Monopar Therapeutics quarterly report, Q1 FY2018
10-Q
2017
Annual report, FY2017
2018.03.26
Monopar Therapeutics annual report, FY2017
10-K
1
...
9
10
11
12
13
14
15
16
News
Monopar: Licensing Agreement, Rolling NDA Submission Serve As Catalysts For ‘Strong Buy’
Prime Medicine: An Initial Prognosis (NASDAQ:PRME)
Monopar Stock: A Rare Disease Asset With Heavy-Metal Upside (Initiating Buy) (NASDAQ:MNPR)
Monopar Therapeutics: ALXN1840's Bull Case Has Improved (NASDAQ:MNPR)
Wall Street Analysts Believe Monopar Therapeutics (MNPR) Could Rally 88.92%: Here's is How to Trade
Monopar names Susan Rodriguez as chief commercial officer
3 Best Stocks to Buy Today, 1/30/2026, According to Top Analysts - TipRanks.com
Monopar Therapeutics stock rating reiterated by Cantor Fitzgerald
BTIG reiterates Buy rating on Monopar Therapeutics stock ahead of NDA submission
Morgan Stanley initiates Monopar Therapeutics stock with Overweight rating
Raymond James reiterates Outperform rating on Monopar stock amid FDA meeting uncertainty
Monopar therapeutics CFO Vu Quan Anh buys $104925 in shares